Publications by authors named "R Michaelson"
Article Synopsis
- - A global trend is shifting outpatient procedures, including sleeve gastrectomy (SG), to ambulatory surgical settings, but more research is needed to confirm safety before broad implementation.
- - This study focuses on collecting data from 365 patients who underwent outpatient laparoscopic sleeve gastrectomy, ensuring it meets the American Society for Metabolic and Bariatric Surgery’s criteria for safety.
- - Results showed low complication rates (1.6%) and no reported mortalities, indicating that same-day discharge after SG can be safe for carefully selected patients in experienced medical centers.
Objective: To compare the outcome of patients with uterine papillary serous cancer (UPSC) carrying a BRCA mutation with that of patients with UPSC who are BRCA wild-type.
Methods: The present retrospective, multicenter cohort study included women with UPSC who were diagnosed between January 1, 1993, and December 31, 2014, and were tested for the BRCA mutation at three Israeli medical centers. Data were collected from the medical records, and patient and tumor characteristics and disease outcomes were compared between BRCA mutation carriers and noncarriers.
LAP-BAND for BMI 30-40: 5-year health outcomes from the multicenter pivotal study.
Int J Obes (Lond)
February 2016
Background: We performed a 5-year multicenter study to evaluate the safety and effectiveness of the LAP-BAND System surgery (LBS) in patients with obesity with a body mass index (BMI) of 30-39.9 kg m(-)(2). This pivotal study was designed to support LBS application to the US Food and Drug Administration for broadening the indications for surgery and the lower BMI indication was approved with 1-year data in 2011, with the intention to complete the 5-year evaluation.
View Article and Find Full Text PDFBackground: Obesity at diagnosis is associated with poor prognosis in women with breast cancer, but few reports have been adjusted for treatment factors.
Methods: CALGB 9741 was a randomized trial of dose density and sequence of chemotherapy for node-positive breast cancer. All patients received doxorubicin, cyclophosphamide, and paclitaxel, dosed by actual body weight.
LAP-BAND for lower BMI: 2-year results from the multicenter pivotal study.
Obesity (Silver Spring)
June 2013
Objective: The goal of this study was to examine the safety and effectiveness of the LAP-BAND System for patients with 30-39.9 BMI and associated comorbidities.
Design And Methods: In this prospective, multicenter, interventional cohort study, subjects with a BMI between 30 and 39.